Sign In
Buy RMD
$188.63
+2.34 (+1.26%)
At Close: Jun 18, 2026
AlphaQuest LLC Grows Stock Position in ResMed Inc. $RMD
03:11am, Friday, 30'th Jan 2026
AlphaQuest LLC raised its position in ResMed Inc. (NYSE: RMD) by 1,038.0% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Com
ResMed Q2 Earnings Call Highlights
01:36am, Friday, 30'th Jan 2026
ResMed (NYSE: RMD) executives highlighted revenue growth, margin expansion and continued investment in product development and demand-generation initiatives during the company's second quarter fiscal
ResMed Inc (RMD) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Innovations
12:04am, Friday, 30'th Jan 2026
Revenue: $1.42 billion, 11% headline increase, 9% constant currency growth.Device Sales Growth: 11% increase globally on a constant currency basis.Masks and Ot
ResMed Inc. (RMD) Q2 2026 Earnings Call Transcript
08:23pm, Thursday, 29'th Jan 2026
ResMed Inc. (RMD) Q2 2026 Earnings Call Transcript
ResMed (RMD) Reports Q2 Earnings: What Key Metrics Have to Say
06:31pm, Thursday, 29'th Jan 2026
The headline numbers for ResMed (RMD) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimat
ResMed (RMD) Q2 Earnings and Revenues Beat Estimates
06:20pm, Thursday, 29'th Jan 2026
ResMed (RMD) came out with quarterly earnings of $2.81 per share, beating the Zacks Consensus Estimate of $2.69 per share. This compares to earnings of $2.43 per share a year ago.
ResMed beats quarterly profit estimates on strong demand for its sleep devices
04:41pm, Thursday, 29'th Jan 2026
Medical device maker ResMed on Thursday beat Wall Street estimates for second-quarter profit on the back of strong demand for its devices used to manage sleep apnea.
Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026
04:05pm, Thursday, 29'th Jan 2026
Note: A webcast of Resmed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com
Here's Why ResMed (RMD) is a Strong Momentum Stock
10:51am, Thursday, 29'th Jan 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Are Medical Stocks Lagging ResMed (RMD) This Year?
10:41am, Thursday, 29'th Jan 2026
Here is how ResMed (RMD) and Compass Therapeutics, Inc. (CMPX) have performed compared to their sector so far this year.
Will ResMed (RMD) Beat Estimates Again in Its Next Earnings Report?
01:11pm, Wednesday, 28'th Jan 2026
ResMed (RMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Stay Ahead of the Game With ResMed (RMD) Q2 Earnings: Wall Street's Insights on Key Metrics
10:15am, Tuesday, 27'th Jan 2026
Besides Wall Street's top-and-bottom-line estimates for ResMed (RMD), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quart
Resmed's Q2 Earnings on Deck: What's in Store for the Stock?
08:56am, Tuesday, 27'th Jan 2026
RMD is set to report Q2 results on Jan. 29, with revenues likely to jump 8.3% and EPS 10.3% as masks, devices and software drive growth.
Why ResMed (RMD) is a Top Growth Stock for the Long-Term
10:45am, Monday, 26'th Jan 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Wealth Enhancement Advisory Services LLC Raises Stake in ResMed Inc. $RMD
05:22am, Saturday, 24'th Jan 2026
Wealth Enhancement Advisory Services LLC lifted its position in ResMed Inc. (NYSE: RMD) by 492.5% in the third quarter, according to the company in its most recent disclosure with the Securities and E
